Escitalopram alters the hypothalamic OX system but does not affect its up-regulation induced by early-life stress in adult rats

Neurosci Res. 2022 Jul:180:58-71. doi: 10.1016/j.neures.2022.02.005. Epub 2022 Feb 25.

Abstract

We hypothesized that there is a relationship between the orexinergic system (OX) alterations and changes elicited by escitalopram or venlafaxine in adult rats subjected to maternal separation (MS). This animal model of childhood adversity induces long-lasting consequences in adult physiology and behavior. Male Wistar rats from the control and MS groups were injected with escitalopram or venlafaxine (10 mg/kg) IP from postnatal day (PND) 69-89. Adult rats were subjected to behavioral assessment, estimation of hypothalamic-pituitary-adrenal (HPA) axis activity and analysis of the OX system (quantitative PCR and immunohistochemistry) in the hypothalamus and amygdala. MS caused anxiety- and depressive-like behavior, endocrine stress-related response, and up-regulation of the OX system in the hypothalamus. Escitalopram, but not venlafaxine, increased the activity of hypothalamic OX system in the control rats and both drugs had no effect on OXs in the MS group. The disturbed signaling of the OX pathway may be significant for harmful long-term consequences of early-life stress. Our data show that the normal brain and brain altered by MS respond differently to escitalopram. Presumably, anti-anxiety and antidepressant effects of this drug do not depend on the activity of hypothalamic OX system.

Keywords: Escitalopram; Maternal separation; Orexins; Venlafaxine.

MeSH terms

  • Animals
  • Escitalopram* / pharmacology
  • Hypothalamus* / metabolism
  • Male
  • Maternal Deprivation
  • Rats
  • Rats, Wistar
  • Stress, Psychological* / metabolism
  • Up-Regulation

Substances

  • Escitalopram